Brian Berman
#161,073
Most Influential Person Now
Brian Berman's AcademicInfluence.com Rankings
Brian Bermanmedical Degrees
Medical
#3241
World Rank
#3700
Historical Rank
Dermatology
#66
World Rank
#90
Historical Rank
Pharmacology
#394
World Rank
#446
Historical Rank
Brian Bermanphilosophy Degrees
Philosophy
#9292
World Rank
#12830
Historical Rank
Logic
#6277
World Rank
#7782
Historical Rank
Download Badge
Medical Philosophy
Brian Berman's Degrees
- PhD Pharmacology University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Brian Berman Influential?
(Suggest an Edit or Addition)Brian Berman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Ingenol mebutate gel for actinic keratosis. (2012) (431)
- Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment (2017) (349)
- Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. (1991) (313)
- Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation (1985) (271)
- Adjunct Therapies to Surgical Management of Keloids (1996) (202)
- A Review of the Biologic Effects, Clinical Efficacy, and Safety of Silicone Elastomer Sheeting for Hypertrophic and Keloid Scar Treatment and Management (2007) (195)
- Two antigenically distinct species of human interferon. (1975) (177)
- Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. (1989) (172)
- Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. (1997) (170)
- Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. (2002) (170)
- Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. (1989) (160)
- Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. (2010) (155)
- Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. (1986) (153)
- Prevention and Management of Hypertrophic Scars and Keloids After Burns in Children (2008) (144)
- Updated International Clinical Recommendations on Scar Management: Part 1—Evaluating the Evidence (2014) (143)
- Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. (1991) (132)
- Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. (1989) (115)
- Treatment of Striae Rubra and Striae Alba With the 585‐nm Pulsed‐Dye Laser (2003) (115)
- Topical treatment of common superficial tinea infections. (2002) (114)
- Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. (2013) (112)
- Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin (1990) (111)
- Anatomical mapping of epidermal Langerhans cell densities in adults (1983) (101)
- Teledermatology and underserved populations. (1997) (100)
- Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy. (1992) (99)
- Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. (1987) (95)
- The treatment of hypertrophic scars and keloids. (1999) (88)
- Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. (1990) (85)
- Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. (1995) (83)
- Modulation of expression of epidermal Langerhans cell properties following in situ exposure to glucocorticosteroids. (1983) (82)
- Treatment of Pigmented Hypertrophic Scars with the 585 nm Pulsed Dye Laser and the 532 nm Frequency‐Doubled Nd:YAG Laser in the Q‐Switched and Variable Pulse Modes: A Comparative Study (2002) (76)
- Expression of Fas‐receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle (2003) (75)
- Innovative therapies in the treatment of keloids and hypertrophic scars. (2010) (75)
- Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloid scars. (1999) (73)
- An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children. (2001) (67)
- Imiquimod 5% Cream for Keloid Management (2003) (67)
- Human herpesviruses 6 and 7. (2002) (66)
- Newer technologies/techniques and tools in the diagnosis of melanoma. (2008) (65)
- Nonsurgical innovations in the treatment of nonmelanoma skin cancer. (2010) (65)
- Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. (2004) (65)
- Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream (2003) (61)
- Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management. (2015) (60)
- Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest (2014) (60)
- Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. (1995) (59)
- Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study. (2009) (57)
- Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis (2003) (56)
- Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis (2011) (56)
- Fatal pancreatitis presenting with subcutaneous fat necrosis. Evidence that lipase and amylase alone do not induce lipocyte necrosis. (1987) (55)
- The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators. (2010) (55)
- Percutaneous dermal drug delivery for local pain control (2006) (54)
- New Therapies for the Management of Keloids (2003) (54)
- Suppression of human interferon production by inhibitors of glycosylation. (1975) (53)
- Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells. (1985) (53)
- Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. (1992) (53)
- New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel (2012) (52)
- Evaluation of Superficial Basal Cell Carcinomas After Treatment With Imiquimod 5% Cream or Vehicle for Apoptosis and Lymphocyte Phenotyping (2003) (49)
- Concurrent cutaneous and hepatic hemangiomata in infancy: report of a case and a review of the literature. (1978) (48)
- Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. (2006) (47)
- Purification, Characterization, and Attempts at Isotopic Labeling of Mouse Interferon (1970) (45)
- Dermatopathology via a still-image telemedicine system: diagnostic concordance with direct microscopy. (1997) (45)
- Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. (1992) (45)
- Cellular binding characteristics of human interferon. (1974) (45)
- Advances in the treatment of keloids. (2011) (44)
- Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS. (1997) (44)
- A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars. (2010) (43)
- Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects. (2015) (42)
- New-onset Majocchi's granuloma in two kidney transplant recipients under tacrolimus treatment. (1998) (42)
- The Histamine H4 Receptor Mediates Inflammation and Pruritus in Th2-Dependent Dermal Inflammation (2011) (40)
- What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. (2012) (39)
- Update on rosacea and anti-inflammatory-dose doxycycline. (2007) (39)
- Novel dermatologic uses of the immune response modifier imiquimod 5% cream. (2002) (38)
- Decrease of ultraviolet A light-induced "common deletion" in healthy volunteers after oral Polypodium leucotomos extract supplement in a randomized clinical trial. (2010) (38)
- Dermatology residency program characteristics that correlate with graduates selecting an academic dermatology career. (2006) (36)
- Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream. (2011) (36)
- Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. (1989) (36)
- Exacerbation of facial acne vulgaris after consuming pure chocolate. (2011) (36)
- Novel Opportunities in the Treatment and Prevention of Scarring (2004) (35)
- Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study (2011) (35)
- Cutaneous disseminated histoplasmosis in AIDS patients in south Florida (1997) (34)
- Pharmacotherapy of actinic keratosis: an update (2012) (33)
- Update on Keloid Management: Clinical and Basic Science Advances. (2012) (33)
- Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha,-beta, and-gamma (2004) (33)
- Pharmacotherapy of actinic keratosis (2009) (33)
- Treatment of Herpes simplex virus infections with topical antiviral agents. (1998) (33)
- Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology (2002) (33)
- Histiocytosis X: treatment with topical nitrogen mustard. (1980) (32)
- Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity? (2015) (31)
- Multicentric reticulohistiocytosis associated with recurrent breast carcinoma. (1998) (31)
- Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results. (2014) (30)
- Pathways to managing atopic dermatitis: consensus from the experts. (2013) (29)
- Polypodium Leucotomos--An Overview of Basic Investigative Findings. (2016) (29)
- Dermal sensitizing potential of glutaraldehyde: a review and recent observations (1984) (28)
- Effects of a water-impermeable, non-silicone-based occlusive dressing on keloids. (1996) (28)
- Complement receptors on guinea pig epidermal Langerhans cells. (1980) (27)
- Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results. (2014) (27)
- Halo giant congenital melanocytic nevus: in vitro immunologic studies. (1988) (26)
- Ecthyma gangrenosum caused by Escherichia coli bacteremia: a case report and review of the literature. (2009) (26)
- Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis. (2006) (26)
- Inpatient adverse cutaneous drug eruptions and eosinophilia. (2001) (25)
- Double-blind, Placebo-controlled Study Assessing the Effect of Chocolate Consumption in Subjects with a History of Acne Vulgaris. (2014) (25)
- Modulation of epidermal langerhans cell properties following in vitro and in situ exposure to gluco cortico steroids (1981) (23)
- Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons. (1998) (23)
- Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids. (2008) (23)
- The Human Interferon System (1982) (23)
- Eruptive seborrheic keratoses in a young woman with acromegaly. (1990) (22)
- Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options (2010) (22)
- Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy. (1985) (22)
- Assessing keloid recurrence following surgical excision and radiation (2020) (21)
- Self‐Warming Lidocaine/Tetracaine Patch Effectively and Safely Induces Local Anesthesia during Minor Dermatologic Procedures (2005) (20)
- Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients (2009) (20)
- Kaposi's sarcoma, chronic ulcerative herpes simplex, and acquired immunodeficiency. (1983) (19)
- Mechanisms of action of new treatment modalities for actinic keratosis. (2006) (19)
- Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids. (2019) (19)
- Ipilimumab: Unleashing the Power of the Immune System Through CTLA-4 Blockade (2012) (19)
- Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT. (2014) (18)
- Double‐Blind, Randomized, Placebo‐Controlled, Prospective Study Evaluating the Tolerability and Effectiveness of Imiquimod Applied to Postsurgical Excisions on Scar Cosmesis (2005) (18)
- The role of imiquimod 3.75% cream in the treatment of external genital warts. (2012) (18)
- What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies. (2012) (18)
- Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis. (1993) (18)
- Quantitation of cutaneous Langerhans cells of sarcoidosis patients. (1983) (18)
- Immunomodulators for skin cancer. (2004) (16)
- Ranking the dermatology programs based on measurements of academic achievement. (2007) (16)
- Subantimicrobial dose doxycycline: a unique treatment for rosacea. (2005) (16)
- Purpura fulminans in a patient with malaria. (2000) (15)
- Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas. (2008) (15)
- Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses (2011) (15)
- Basal cell carcinoma presenting as a chronic finger ulcer. (1990) (15)
- Determination of the Area of Skin Capable of Being Covered by the Application of 250 mg of 5% Imiquimod Cream (2004) (14)
- Treatment of warts (2000) (14)
- MD/PhDs are more likely than MDs to choose a career in academic dermatology. (2008) (14)
- Dermatologic uses of interferons. (1995) (14)
- Histochemical analysis of Langerhans' cells. (1979) (14)
- Do postsurgical interventions optimize ultimate scar cosmesis. (2009) (14)
- Tolerability of Topical Treatments for Atopic Dermatitis (2019) (14)
- A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment. (2018) (13)
- Topical antiviral agents for herpes simplex virus infections. (1998) (13)
- Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis (2015) (13)
- A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9 (2011) (13)
- Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap. (2012) (13)
- A controlled cohort study examining the onset of hypertension in black patients with keloids. (2002) (12)
- Membrane-bound intracellular interferon in rabbit kidney cell cultures. (1972) (12)
- Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS. (2010) (12)
- Targeted treatment of pruritus: a look into the future (2012) (12)
- Skin metastases from small-cell carcinoma of the lung. (1983) (11)
- Localized indurated brown plaques on arms and right buttock. Pentazocine-induced morphea. (1996) (11)
- Ultrasonic assessment of cutaneous atrophy caused by intradermal corticosteroids. (1982) (11)
- Immunological strategies to fight skin cancer. (2006) (10)
- T6-antigen-bearing cells in eosinophilic granuloma of bone. (1983) (10)
- Cultured fibroblasts in avian scleroderma, an autoimmune fibrotic disease, display an activated phenotype. (1992) (10)
- Photobiomodulation with non-thermal lasers: Mechanisms of action and therapeutic uses in dermatology and aesthetic medicine (2017) (10)
- Variables in Cryosurgery Technique Associated With Clearance of Actinic Keratosis (2017) (9)
- Integrating Skin Cancer-Related Technologies into Clinical Practice. (2017) (9)
- A novel hydrogel scaffold for the prevention or reduction of the recurrence of keloid scars postsurgical excision. (2013) (9)
- Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment (2019) (9)
- Mononuclear cells isolated from fibrotic skin lesions in avian scleroderma constitutively produce fibroblast-activating cytokines and immunoglobulin M. (1995) (9)
- Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients. (2018) (8)
- Biological Agents for Controlling Excessive Scarring (2010) (8)
- HIV and AIDS in inpatient dermatology. Approach to the consultation. (2000) (8)
- Immune Response Following Photodynamic Therapy For Bladder Cancer (1989) (8)
- A Retrospective Registry Study Evaluating the Long-Term Efficacy and Safety of Superficial Radiation Therapy Following Excision of Keloid Scars. (2020) (8)
- Objective Assessment of the Precision, Accuracy, and Reliability of a Measurement Method for Keloid Scar Volume (PARKS Study) (2015) (7)
- Successful treatment of butcher's warts with imiquimod 5% cream (2003) (7)
- Establishment of a cell line retaining Langerhans cell characteristics. (1980) (7)
- Rethinking the Journal Impact Factor and Publishing in the Digital Age. (2020) (7)
- Understanding the Role of Photolyases: Photoprotection and Beyond. (2017) (7)
- Trypsin inihibitors inhibit induction by interferon-γ of HLA-DR antigen expression on human skin cells (1989) (6)
- Dermatoglyphic patterns in patients with atopic dermatitis. (1983) (6)
- Safety and Efficacy of Aminolevulinic Acid 10% Topical Gel versus Aminolevulinic Acid 20% Topical Solution Followed by Blue-light Photodynamic Therapy for the Treatment of Actinic Keratosis on the Face and Scalp: A Randomized, Double-blind Study. (2019) (6)
- Tumor necrosis factor-α (TNF-α), interferon-α (IFN-α) and interferon-γ (IFN-γ) receptors on human normal and scleroderma dermal fibroblasts in vitro (1992) (6)
- The aging skin. (1985) (6)
- The effectiveness of a new method for assessing induration. (1998) (6)
- Efficacy Endpoints in Clinical Trials in Actinic Keratosis (2018) (5)
- Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest. (2017) (5)
- Antivirals in dermatology. (1995) (5)
- Genetic variations in toll-like receptor pathway genes influence asthma and atopy (2012) (5)
- Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis (2011) (5)
- Chemoprevention of Chemically Induced Skin Tumorigenesis by Ligand Activation of Peroxisome Proliferator–Activated Receptor-β/δ and Inhibition of Cyclooxygenase 2 (2012) (5)
- Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis (2014) (5)
- Erratum: Teledermatology and underserved populations (Archieves of Dermatology (Feb. 1997) 133 (197-200)) (1997) (5)
- Field Treatment of Actinic Keratosis With Ingenol Mebutate. (2016) (4)
- Role of Langerhans Cells in Cutaneous Immunological Reactions (1981) (4)
- Successful management of viral infections and other dermatoses with imiquimod 5% cream. (2003) (4)
- Evaluation of interferon alpha2 (SCH 30500) in the treatment of condyloma acuminatum (1988) (4)
- Graduates-of-foreign-dermatology residencies and military dermatology residencies and women in academic dermatology. (2009) (4)
- Interpretation of potassium hydroxide wet mounts by means of telemicroscopy. (1997) (3)
- Contact allergy to sulfonated castor oil (1981) (3)
- Characterization of a glucocorticosteroid-induced inhibitor of interferon-gamma induction of HLA-DR expression. (1992) (3)
- Cytokines and Chemokines (2008) (3)
- Cutaneous signs and syndromes associated with internal malignancies. (2005) (3)
- Reduced epidermal Langerhans cell densities in patients with pulmonary malignancies do not correlate with anergy or nutritional status. (1985) (3)
- Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis. (2017) (3)
- Efficacy of aminolevulinic acid 20% solution combined with photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial. (2020) (3)
- Three-day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: A Phase II Trial. (2017) (3)
- Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action (2022) (2)
- Genital herpes infection: beyond a clinical diagnosis. (2003) (2)
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (2020) (2)
- American board of dermatology certification examination: preparation and perceptions. (2002) (2)
- Epidermal Langerhans cell density in patients with pulmonary malignancies and chronic obstructive pulmonary disease. (1987) (2)
- Induction of HLA-DR by Interferon-γ Requires a Trypsin-Like Protease (1991) (2)
- A genome-wide association study to identify genetic determinants of atopy in subjects from the United Kingdom (2012) (2)
- Sinecatechins Ointment, 15% for the Treatment of External Genital and Perianal Warts: Proceedings of an Expert Panel Roundtable Meeting. (2016) (2)
- What ’ s New in Natural Compounds for Photoprotection ? (2)
- Localized Indurated Brown Plaques on Arms and Right Buttock (1996) (2)
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study. (2016) (2)
- Tumor necrosis factor-alpha (TNF-alpha), interferon-alpha (IFN-alpha) and interferon-gamma (IFN-gamma) receptors on human normal and scleroderma dermal fibroblasts in vitro. (1992) (2)
- The Effect of Topical Maalox on Transdermal Clonidine-Induced Contact Dermatitis (1992) (2)
- Discussion: research update on external genital warts and other viral dermatoses (2003) (2)
- Revisiting Handwashing - As It Is Absolutely Essential. (2020) (2)
- Fas-ligand staining in non-drug- and drug-induced maculopapular rashes (2012) (2)
- Rating the 4-Star UVA Protection Rating System (2010) (2)
- Treatment of Keloids and Scars (2013) (2)
- A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer (2011) (2)
- 15580 Effect of TGF-β1/COX-2 small interfering RNA combination product (STP705) on cell viability and tumor growth in a human squamous carcinoma xenograft tumor model in nude mice (2020) (2)
- Immune Response Modulators in the Treatment of Skin Cancer (2011) (2)
- Is eosinophilia helpful in diagnosing drug eruptions? (2002) (2)
- Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies (2020) (2)
- Low Rate of Keloid Recurrences Following Treatment of Keloidectomy Sites with a Biologically Effective Dose 30 of Superficial Radiation (2017) (2)
- Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial. (2017) (2)
- A new era: melanoma genetics and therapeutics (2012) (1)
- Induction of HLA-DR by interferon-gamma requires a trypsin-like protease. (1991) (1)
- Letter: A comparison study of the tensile strength of sutures used in dermatologic surgery following exposure to petrolatum. (2011) (1)
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA). (2017) (1)
- Trypsin inhibitors inhibit induction by interferon-gamma of HLA-DR antigen expression on human skin cells. (1989) (1)
- Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by. (2016) (1)
- Efficacy of a Silicone-Based Gel Containing Pracaxi Oil (Pentaclethra macroloba) for Treating Post-Surgical Scars (2018) (1)
- Pharmacotherapy of Basal Cell Carcinoma, Anogenital Warts, and Actinic Keratoses: Focus on Topical Imiquimod (2011) (1)
- Effects of Imiquimod 5% Cream in the Prevention of Excised Keloid Recurrence (2018) (1)
- The stratum corneum revisited: a new understanding of its role in healthy and diseased skin. Introduction. (2011) (1)
- Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report. (2021) (1)
- Lentiginous Melanoma In Situ Treatment With Topical Imiquimod: Need for Individualized Regimens (2012) (1)
- The Area Capable of Being Covered by the Application of 250mg of Tirbanibulin Ointment. (2022) (1)
- Toxic epidermal necrolysis in the setting of systemic lupus erythematosus (2011) (1)
- An Investigator Blinded Randomized Study Evaluating HOCl in the Treatment of Atopic Dermatitis-Associated Pruritus (2017) (1)
- The Effect of Combined Steroid and Calcium Channel Blocker Injection on Human Hypertrophic Scars in Animal Model: A New Strategy for the Treatment of Hypertrophic Scars (2012) (1)
- Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease (2011) (0)
- 2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and Care. (2022) (0)
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT (2011) (0)
- Treating scars and laser resurfacing in 2021 (2020) (0)
- Molluscum Contagiosum Virus Evasion of Immune Surveillance: A Review. (2023) (0)
- 1614TiPA Phase I safety study of topical Calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA) (2017) (0)
- Letters to the Editor (1998) (0)
- Observer-Blinded, Randomized Study to Determine the Safety and Efficacy of a Silicone Gel versus a Gel Containing Onion Extract for the Appearance and Symptoms of Surgical Scars (2017) (0)
- Vaccines for Viral Diseases (2011) (0)
- Efficacy of ALA–PDT in the Treatment of Actinic Keratoses on the Upper Extremities: A Post Hoc Analysis of a Phase 3, Randomized, Vehicle-Controlled Trial (2020) (0)
- Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers (2011) (0)
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results. (2018) (0)
- Distribution of neutralizing antibodies against leukocyte and fibroblast interferons in rabbits immunized with leukocyte orfibroblast interferons (0)
- 274 Complete clearance of actinic keratosis observed from day 8 of tirbanibulin treatment, along with good tolerability: post-hoc analysis of two Phase 3 studies (2022) (0)
- Updates on Keloidal Wound Healing (2016) (0)
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results. (2019) (0)
- 14087 Integrating genomics for the diagnosis and prognosis of melanoma into clinical practice (2020) (0)
- Visual and Pathologic Analyses of Keloid Growth Patterns (2011) (0)
- Abstract 2328: Interrogating the anti-cancer effects of co-enzyme Q10 (CoQ10) identifies metabolic and mitochondrial apoptotic responses as primary mechanisms in squamous cell carcinoma model (2021) (0)
- 13568 Efficacy of ALA-PDT in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial (2020) (0)
- A pilot study on the effects of topical antifungal and corticosteroid preparations in an in vitro model of human superficial fungal infection (2005) (0)
- Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis (2011) (0)
- Profile of Tirbanibulin for the Treatment of Actinic Keratosis. (2022) (0)
- Anti-IgE Therapy (2018) (0)
- Regulation of collagen and glycosaminoglycan biosynthesis by human breast implant capsule fibroblasts by interferons-alpha, -beta and -gamma and pentoxifylline (1995) (0)
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA) (2017) (0)
- An overview of superficial radiation of surgical keloidectomy sites to reduce keloid recurrences (2020) (0)
- Prevention of Tuberculosis Infections in Patients Considered for Anti-TNF-α Therapy: Practical Application of National Psoriasis Foundation Consensus Statement (2010) (0)
- FULMINANT HEAD AND NECK CONGESTION IN ADVANCED CUTANEOUS T CELL LYMPHOMA: A POOR PROGNOSTIC INDICATOR (1995) (0)
- Safety and Efficacy of TGF-β1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ. (2022) (0)
- Iconography : Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons (2011) (0)
- Efficacy and safety of ingenol disoxate gel in field treatment of actinic keratosis on full face, scalp or large area (250 cm2) on the chest: results of four phase 3 randomized controlled trials. (2020) (0)
- Introduction—Treating scars and laser resurfacing in 2021—Part B (2021) (0)
- A butterfly chest rash bordering a sternotomy scar (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Brian Berman?
Brian Berman is affiliated with the following schools:
